Gastric motility in rats with varying ovarian hormone status.

West J Nurs Res

Department of Physiological Nursing, University of Washington, Seattle.

Published: February 1995

Gastrointestinal (GI) symptoms suggestive of altered motility vary with menstrual cycle phase and menopause, but the effects of ovarian hormones on gastric motility have not been described. Basal and stimulated gastric motility were studied in male and female rats that were ovariectomized and implanted with continuous-release progesterone and/or estrogen pellets. Following 26 days of hormone treatment, rats were implanted with a gastric tension transducer. Contractile activity was recorded, then thyrotropin-releasing hormone (TRH) or saline was injected intracisternally and motility was monitored. An index was calculated based on frequency and amplitude; response to TRH was expressed as percentage of the basal index. Basal contraction frequency was highest in the estrogen and estrogen+progesterone groups. Hormone treatment significantly affected the TRH-stimulated motility index; TRH induced increased motility in all groups, with larger, more sustained responses in vehicle, progesterone, and male groups. Results demonstrate the ovarian hormone modulation of basal and stimulated gastric motility. Such modulation may contribute to changes in GI symptoms with altering ovarian hormone state.

Download full-text PDF

Source
http://dx.doi.org/10.1177/019394599501700102DOI Listing

Publication Analysis

Top Keywords

gastric motility
16
ovarian hormone
12
basal stimulated
8
stimulated gastric
8
hormone treatment
8
motility
7
hormone
6
gastric
5
motility rats
4
rats varying
4

Similar Publications

Introduction: Patient-controlled intravenous analgesia (PCIA) and patient-controlled epidural analgesia (PCEA) constitute two major advances in pain management after major abdominal surgery. However, the role of PCIA or PCEA has not been particularly studied in elderly patients with gastric cancer. The aim of this study is to make a comparison between PCIA and PCEA in terms of their performance on short-term outcomes in elderly patients undergoing laparoscopic-assisted gastrectomy.

View Article and Find Full Text PDF

The multifaceted roles of aldolase A in cancer: glycolysis, cytoskeleton, translation and beyond.

Hum Cell

January 2025

Institute of Translational Medicine, Medical College, Yangzhou University, No. 136 Jiangyangzhonglu, Yangzhou, 225009, Jiangsu, China.

Cancer, a complicated disease characterized by aberrant cellular metabolism, has emerged as a formidable global health challenge. Since the discovery of abnormal aldolase A (ALDOA) expression in liver cancer for the first time, its overexpression has been identified in numerous cancers, including colorectal cancer (CRC), breast cancer (BC), cervical adenocarcinoma (CAC), non-small cell lung cancer (NSCLC), gastric cancer (GC), hepatocellular carcinoma (HCC), pancreatic cancer adenocarcinoma (PDAC), and clear cell renal cell carcinoma (ccRCC). Moreover, ALDOA overexpression promotes cancer cell proliferation, invasion, migration, and drug resistance, and is closely related to poor prognosis of patients with cancer.

View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) exhibits a high incidence globally, with the liver being the most common site of distant metastasis. At the time of diagnosis, 20-30% of CRC patients already present with liver metastases. Colorectal liver metastasis (CRLM) is a major cause of mortality among CRC patients.

View Article and Find Full Text PDF

The barium swallow study is a fluoroscopic study which provides valuable insights into the motility, function and morphology of the pharynx, oesophagus, gastroesophageal junction, proximal stomach and duodenum. It has been observed that the skill of radiology doctors with barium swallow studies in adults has diminished. This reduced proficiency with barium swallow study is closely linked to and perpetuated by the heterogeneity of technique amongst radiologists.

View Article and Find Full Text PDF

Rapid-release and user-friendly costunolide/dehydrocostuslactone hydrophilic nanofibers: Therapeutic effects on acute gastric ulcers.

Int J Pharm

January 2025

Holistic Integrative Medicine Industry Collaborative Innovation Research Center, Qiang Medicine Standard Research Promotion Base and Collaborative Innovation Research Center, School of Preclinical Medicine, Chengdu University, Sichuan-Chengdu 610106, China. Electronic address:

Gastric ulcers often cause postprandial epigastric pain, especially in acute cases. Abnormal motility, with about 50 % of patients having delayed gastric emptying, contributes to ulcer development. Costunolide (COS) and dehydrocostuslactone (DEH), derived from "Mu xiang" herbs, show potential in treating ulcers and regulating gastrointestinal motility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!